Mizuho Issues Positive Forecast for Ventas (NYSE:VTR) Stock Price

Ventas (NYSE:VTR) had its price target lifted by Mizuho from $87.00 to $94.00 in a report released on Wednesday,Benzinga reports. Mizuho currently has an outperform rating on the real estate investment trust’s stock.

VTR has been the topic of a number of other reports. Citigroup upped their price target on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Wells Fargo & Company upped their target price on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Argus set a $88.00 price target on Ventas in a report on Tuesday, February 10th. KeyCorp boosted their price target on Ventas from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research report on Monday, February 9th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $89.00.

Ventas Stock Performance

Shares of Ventas stock opened at $86.78 on Wednesday. The company has a market capitalization of $41.22 billion, a PE ratio of 160.70, a P/E/G ratio of 2.12 and a beta of 0.73. The company has a 50-day simple moving average of $80.44 and a two-hundred day simple moving average of $75.52. Ventas has a one year low of $60.15 and a one year high of $87.87. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Research analysts expect that Ventas will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. Ventas’s dividend payout ratio is presently 355.56%.

Insider Buying and Selling

In other news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. The trade was a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in VTR. AG Campbell Advisory LLC acquired a new stake in Ventas during the 4th quarter worth about $388,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of Ventas by 802.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,960 shares of the real estate investment trust’s stock worth $229,000 after buying an additional 2,632 shares during the last quarter. Reflection Asset Management acquired a new stake in Ventas during the fourth quarter worth about $34,000. Tobam raised its position in Ventas by 2,479.1% during the fourth quarter. Tobam now owns 4,436 shares of the real estate investment trust’s stock valued at $343,000 after acquiring an additional 4,264 shares in the last quarter. Finally, Alpine Global Management LLC acquired a new position in Ventas in the fourth quarter valued at approximately $235,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.